Creatine for Cognitive Function

The brain consumes about 20% of resting energy expenditure despite weighing only 2% of body mass. That extraordinary ATP demand is met by oxidative phosphorylation in neuronal mitochondria, but with a critical assist from the same creatine kinase / phosphocreatine system that buffers ATP regeneration in skeletal muscle. The Rae 2003 randomized crossover trial in Proceedings of the Royal Society B was the first rigorous demonstration that oral creatine supplementation measurably improves cognitive performance in healthy young adults — specifically on working memory and Raven's intelligence-test items under time pressure. Avgerinos 2018 then pooled the subsequent literature in a systematic review and meta-analysis, finding the effect concentrated in conditions of energy stress: sleep deprivation, cognitive fatigue, and (most strikingly) in vegetarians and vegans whose baseline brain creatine is significantly lower than in omnivores. This deep-dive walks through the brain bioenergetics, the foundational trials, the vegetarian effect, the sleep-deprivation rescue, the emerging mood and depression literature, and what the evidence does and does not yet support.

Table of Contents

  1. The Brain's Extraordinary ATP Demand
  2. Creatine Kinase in the Brain — the Same Mechanism, Different Tissue
  3. The Rae 2003 Foundational Trial
  4. The Avgerinos 2018 Meta-Analysis
  5. The Vegetarian and Vegan Brain-Creatine Response — the Largest Effect Documented
  6. Sleep-Deprivation Cognitive Rescue
  7. Mental Fatigue and Demanding Cognitive Tasks
  8. Depression, Mood, and the Emerging Psychiatric Literature
  9. Traumatic Brain Injury and Neuroprotection
  10. Dosing Considerations for Brain Effects (May Differ from Muscle)
  11. What the Evidence Does Not (Yet) Show
  12. Key Research Papers
  13. Connections

The Brain's Extraordinary ATP Demand

The human brain is a metabolic outlier among organs. By mass it accounts for roughly 2% of body weight in adults, but it consumes approximately 20% of resting energy expenditure — roughly 300-400 kilocalories per day, all of it derived from oxidative phosphorylation of glucose (under most conditions) or ketone bodies (during fasting or ketogenic diets). The energy is spent on the work of maintaining ion gradients across neuronal membranes against constant leak, on neurotransmitter synthesis and recycling, on synaptic vesicle cycling, and on action-potential conduction.

The ATP demand is not uniform across the brain or across time. It rises sharply during cognitive work — the prefrontal cortex during working-memory tasks, the hippocampus during memory encoding, the visual cortex during attention-demanding viewing. Functional brain imaging studies show measurable local rises in glucose uptake (positron-emission tomography) and blood flow (functional MRI) precisely in the regions most engaged by a task. The ATP these regions consume must be rapidly regenerated from ADP, and like muscle, the brain has multiple mechanisms in parallel to do this regeneration.

The phosphocreatine / creatine kinase system is one of those mechanisms. Brain tissue contains significant intracellular creatine (the total creatine peak in the brain is one of the most prominent on a magnetic resonance spectroscopy scan, used clinically as a metabolic reference), and brain creatine kinase isoforms are expressed both in neurons and in glial cells. The system buffers acute ATP demand spikes in essentially the same way it does in muscle — phosphocreatine donates a phosphate to ADP, restoring ATP rapidly while slower mitochondrial regeneration catches up.

The implication: anything that increases the available phosphocreatine pool in the brain should, in principle, improve the brain's capacity to meet acute ATP demand spikes. Cognitive tasks that are most ATP-demanding (under sustained attention, time pressure, sleep deprivation, or in individuals with marginally low baseline brain creatine) should be the ones that show the largest response. That is exactly what the clinical literature has documented.

Back to Table of Contents

Creatine Kinase in the Brain — the Same Mechanism, Different Tissue

Creatine kinase exists in four isoforms in mammalian tissue: muscle (MM, primarily skeletal muscle), brain (BB, primarily neural tissue), heart (MB, a heterodimer historically used as a cardiac infarct marker), and mitochondrial (uMtCK and sMtCK, located in the mitochondrial intermembrane space). The brain BB isoform is expressed in both neurons and astrocytes, with particularly high expression in the cerebellum, hippocampus, and cortex.

The reaction is identical regardless of tissue: PCr + ADP + H⁺ ↔ Cr + ATP. The reaction is reversible and operates near equilibrium, so the direction depends on local ADP / ATP / phosphocreatine concentrations. Under high ATP demand (firing neuron, contracting muscle fiber), the equilibrium shifts toward ATP regeneration. Under low ATP demand and high ATP availability (resting tissue), the equilibrium shifts back toward phosphocreatine recharging.

This near-equilibrium behavior is biochemically elegant: it lets the creatine kinase system act as a "fast battery" that buffers transient ATP demand mismatches between the slow oxidative supply line (mitochondria) and the rapid ATP consumption (membrane pumps, action potentials, synaptic activity). The system has been called a "temporal" and "spatial" energy buffer: temporal in the sense of smoothing fast spikes in demand, spatial in the sense of transporting energy from mitochondria (where ATP is made) to the cytosolic sites where ATP is used.

The Dechent et al. (Am J Physiol 1999) study used magnetic resonance spectroscopy to measure total brain creatine in healthy adults before and after 4 weeks of 20 g/day oral creatine supplementation. Brain total creatine rose by an average of 8.7%. The change was statistically significant and confirmed that oral creatine crosses the blood-brain barrier (slowly, via the SLC6A8 transporter) and reaches brain tissue. The rise is smaller than the 20-40% increase seen in skeletal muscle — the blood-brain barrier is a more selective gatekeeper than the sarcolemma — but it is measurable and reproducible.

Back to Table of Contents

The Rae 2003 Foundational Trial

The most-cited cognitive trial of creatine is Rae et al. (Proceedings of the Royal Society B 2003), conducted at the University of Sydney. The study used a double-blind placebo-controlled crossover design in 45 healthy vegetarian young adults. Each subject received six weeks of oral creatine monohydrate (5 g/day) and six weeks of placebo, with a six-week washout between phases. The crossover design controls for individual variation in baseline cognitive ability — each subject is their own control.

Cognitive performance was measured using two standardized batteries: the Raven's Advanced Progressive Matrices (a non-verbal reasoning / "fluid intelligence" test) administered under time pressure, and a digit-span backward task (a working-memory test). Both are demanding cognitive tasks that produce measurable individual variation and are sensitive to acute interventions in healthy adults.

Results:

The choice of a vegetarian sample was deliberate. Vegetarians get essentially no dietary creatine (creatine is found almost exclusively in animal tissue — red meat, fish, poultry, with trace amounts in dairy). Their baseline brain creatine is lower than omnivores by approximately 10-15% on average, which means they have more headroom for supplementation to produce a measurable effect. The Rae trial was designed to give creatine its best shot at showing a brain effect by recruiting the population most likely to be deficient.

Subsequent trials in omnivorous populations have generally found smaller effects on the same cognitive endpoints, consistent with the lower headroom for improvement. But the foundational finding — that brain creatine concentration responds to oral supplementation and that the response is associated with measurable cognitive performance change — is well-established.

Back to Table of Contents

The Avgerinos 2018 Meta-Analysis

Avgerinos KI et al. (Experimental Gerontology 2018) conducted the most comprehensive systematic review to date of cognitive endpoints in randomized creatine trials. The review pooled six randomized controlled trials meeting inclusion criteria for healthy adult cognitive endpoints. Their key findings:

The take-home from the Avgerinos meta-analysis aligns with the underlying mechanism: creatine is a buffer for ATP-demand spikes. The buffer matters more when supply is constrained (low brain creatine, sleep deprivation, mental fatigue, hypoxia) than when the system is operating at baseline with adequate margin. The supplement does not raise IQ in well-rested healthy young adults. It does protect cognitive function under stress and it does close the cognitive gap that vegetarians and vegans experience relative to omnivores.

Updated reviews by Roschel et al. (Nutrients 2021) and Forbes et al. (Nutrients 2022) reach essentially the same conclusions with additional data — brain creatine matters, the response is heterogeneous, and the largest effects show up in deficient or stressed populations.

Back to Table of Contents

The Vegetarian and Vegan Brain-Creatine Response — the Largest Effect Documented

The single most reproducible cognitive finding in the creatine literature is that vegetarians and vegans show larger response than omnivores. This makes biological sense because of how creatine is sourced:

The net result: omnivores have a total daily creatine availability of approximately 2-3 g, vegetarians have about 1 g (synthesis only), and vegans have about 1 g. Over years and decades, this difference in availability translates to measurably lower body creatine stores in plant-based eaters — lower muscle creatine (by 10-15% on average) and lower brain creatine (by a similar margin in MRS studies).

The Benton & Donohoe (Br J Nutr 2011) trial was specifically designed to test the vegetarian-vs-omnivore response. The study supplemented 121 young women (split between vegetarians and omnivores) with either creatine or placebo for five days, then tested cognitive performance:

The practical implication is clinically actionable: vegetarian and vegan patients reporting brain fog, mental fatigue, difficulty with cognitively demanding work, or simply wanting to optimize cognitive function should consider creatine supplementation as a first-line intervention. The evidence base is stronger for this specific subpopulation than for any other cognitive use case. 3-5 g/day of creatine monohydrate is sufficient to close the dietary gap and bring brain creatine toward omnivore levels within 4-6 weeks.

Vegetarian and vegan readers should also consider that the muscle benefit of creatine is similarly larger in their subpopulation — the supplement is even more compelling for plant-based eaters who also strength train. See the Muscle Strength & Performance deep-dive for that side of the story.

Back to Table of Contents

Sleep-Deprivation Cognitive Rescue

The most strikingly large cognitive effects of creatine show up under sleep deprivation, which is essentially a sustained ATP-demand stress on the brain. Sleep restriction degrades mitochondrial function, reduces glucose utilization efficiency in the prefrontal cortex, and depletes neuronal ATP reserves. Cognitive performance degrades correspondingly — reaction time slows, working memory shrinks, complex decision-making becomes error-prone.

McMorris T et al. (Psychopharmacology 2006) was an influential trial in this space. Subjects were randomized to either creatine (20 g/day loading for 7 days, then 5 g/day) or placebo, then put through a battery of cognitive and psychomotor tests under 24-hour sleep deprivation. The creatine group showed substantially better performance on tests of mental fatigue and reaction time at the sleep-deprived measurement than placebo. The effect persisted at 36-hour sleep deprivation, suggesting cumulative protective effect.

Watanabe et al. (Neurosci Res 2002) used near-infrared spectroscopy to measure cerebral hemoglobin oxygenation during a mathematical task. Creatine supplementation reduced mental fatigue accumulation and was associated with measurable changes in regional brain oxygen utilization, supporting the bioenergetic mechanism.

The practical applications:

The mechanism is the same as in muscle: a larger phosphocreatine buffer protects against degradation under stress. The brain just happens to be the tissue under stress in these scenarios rather than skeletal muscle.

Back to Table of Contents

Mental Fatigue and Demanding Cognitive Tasks

Mental fatigue — the subjective and objective decline in cognitive performance after sustained cognitive effort — involves a measurable depletion of cortical metabolic substrate. The phenomenon is well-documented in laboratory paradigms (the AX-Continuous Performance Task, the Stroop test, dual N-back) and in real-world settings (afternoon decision-making decline, end-of-shift error rates, late-day surgical complication rates).

Creatine supplementation modestly attenuates mental-fatigue accumulation in trials that have specifically tested this. The Watanabe trial cited above is one example; subsequent work in office workers, students preparing for examinations, and professional populations has shown similar patterns. The effect is most reliable when the cognitive task is sustained over 30-60+ minutes (long enough for fatigue to accumulate) and demanding enough to draw on the phosphagen buffer.

Brief acute tasks in well-rested individuals show little or no creatine effect. The supplement is not a stimulant or a cognitive enhancer in the popular sense. It is an energy-buffer that becomes useful precisely when energy supply starts to constrain performance.

For sustained cognitive work, creatine is best combined with the other obvious interventions: adequate sleep, regular movement, periodic breaks (the Pomodoro discipline or equivalent), adequate hydration, and a well-managed caffeine routine. Stacking these factors is more powerful than any single intervention.

Back to Table of Contents

Depression, Mood, and the Emerging Psychiatric Literature

An emerging but still preliminary literature suggests creatine may have utility as an adjunct in major depressive disorder, particularly in women and particularly when SSRIs alone produce incomplete response. The mechanistic hypothesis: depression is associated with disturbed brain bioenergetics and reduced phosphocreatine in specific brain regions on MRS, and creatine supplementation may help restore that bioenergetic environment.

Key trials and findings:

The evidence remains preliminary and the sex-specificity (more reliable in women than men) is unexplained. None of these trials are large enough to change clinical practice on their own. But the consistent direction of effect, the mechanistic plausibility, and the excellent safety profile have led some psychiatric practitioners to recommend a trial of creatine as a low-cost adjunct in difficult-to-treat depression, particularly in female patients. For more on depression and adjunctive strategies, see our Depression page.

Creatine should never be presented as a substitute for evidence-based depression treatment (psychotherapy, SSRIs/SNRIs, lifestyle intervention, ECT in severe cases). It may be a useful adjunct that does no harm and may help.

Back to Table of Contents

Traumatic Brain Injury and Neuroprotection

Animal models of traumatic brain injury (controlled cortical impact, fluid percussion injury) consistently show that creatine pre-treatment reduces lesion volume, preserves cognitive function in behavioral testing, and improves recovery trajectories. The mechanism is hypothesized to involve restoration of post-injury bioenergetic failure — injured brain tissue suffers ATP depletion, mitochondrial dysfunction, and calcium dysregulation, all of which the expanded phosphocreatine reservoir helps buffer.

Human evidence is sparse but suggestive. Sakellaris et al. studied creatine supplementation in children and adolescents with traumatic brain injury and reported improved post-traumatic amnesia, lower rate of post-traumatic headache, and faster return to baseline cognitive function. The trial was small and the results require replication.

Dolan et al. (Eur J Sport Sci 2019) reviewed the broader "beyond muscle" literature including TBI and concluded that the mechanistic case for creatine as neuroprotective is strong but that large RCTs in acute TBI populations remain to be done. The supplement has been quietly adopted by some sports-medicine programs for athletes with concussion history, on the theory that the safety profile permits a prudent off-label trial even without definitive RCT evidence.

This is an area where the evidence is suggestive but not yet practice-changing. Patients with recent or repeated concussions interested in adjunct nutritional support should discuss with their treating physician.

Back to Table of Contents

Dosing Considerations for Brain Effects (May Differ from Muscle)

Most clinical trials of cognitive endpoints have used either the standard 5 g/day maintenance protocol or the loading-then-maintenance protocol (20 g/day for 5-7 days, then 5 g/day). Both regimens have produced positive cognitive findings in the appropriate populations.

One open question is whether brain creatine equilibration may require a longer or higher-dose protocol than muscle, because:

The evidence base does not yet definitively settle this question. The reasonable default for brain effects is the same 5 g/day used for muscle, given for at least 8 weeks (longer than the 4 weeks typically used for muscle endpoints) before assessing response. Individuals can consider escalating to 10 g/day if 5 g/day produces no noticeable effect after 8 weeks — this dose has been used safely in long-term trials.

Pairing creatine with adequate baseline nutrition is also important. The brain requires the substrate of normal cognition: adequate sleep, regular protein intake (the precursors for endogenous creatine synthesis), adequate B vitamins (methyl-donor metabolism), and adequate omega-3 fatty acids (membrane phospholipid composition). Creatine helps a brain that has the other necessary inputs; it cannot substitute for them.

Back to Table of Contents

What the Evidence Does Not (Yet) Show

Honesty about the limits of the cognitive evidence matters:

What the evidence does support: creatine measurably raises brain creatine, the rise correlates with cognitive performance improvement on demanding tasks under stress, the effect is largest in vegetarians and vegans, and the safety profile permits a trial in essentially any patient interested in cognitive optimization. That is enough to recommend it in many specific clinical contexts. It is not enough to recommend it as a universal cognitive enhancer for healthy young adults.

Back to Table of Contents

Key Research Papers

  1. Rae C, Digney AL, McEwan SR, Bates TC (2003). Oral creatine monohydrate supplementation improves brain performance: a double-blind, placebo-controlled, cross-over trial. Proc R Soc B 270(1529):2147-2150. — PubMed
  2. Avgerinos KI et al. (2018). Effects of creatine supplementation on cognitive function of healthy individuals: a systematic review of randomized controlled trials. Exp Gerontol 108:166-173. — PubMed
  3. Benton D, Donohoe R (2011). The influence of creatine supplementation on the cognitive functioning of vegetarians and omnivores. Br J Nutr 105(7):1100-1105. — PubMed
  4. Watanabe A, Kato N, Kato T (2002). Effects of creatine on mental fatigue and cerebral hemoglobin oxygenation. Neurosci Res 42(4):279-285. — PubMed
  5. McMorris T et al. (2006). Effect of creatine supplementation and sleep deprivation, with mild exercise, on cognitive and psychomotor performance, mood state, and plasma concentrations of catecholamines and cortisol. Psychopharmacology 185(1):93-103. — PubMed
  6. Dechent P et al. (1999). Increase of total creatine in human brain after oral supplementation of creatine-monohydrate. Am J Physiol 277(3 Pt 2):R698-704. — PubMed
  7. Roschel H, Gualano B et al. (2021). Creatine supplementation and brain health. Nutrients 13(2):586. — PubMed
  8. Forbes SC et al. (2022). Effects of creatine supplementation on brain function and health. Nutrients 14(5):921. — PubMed
  9. Lyoo IK et al. (2012). A randomized, double-blind placebo-controlled trial of oral creatine monohydrate augmentation for enhanced response to a selective serotonin reuptake inhibitor in women with major depressive disorder. Am J Psychiatry 169(9):937-945. — PubMed
  10. Kondo DG et al. (2011). Open-label adjunctive creatine for female adolescents with SSRI-resistant major depressive disorder: a 31-phosphorus magnetic resonance spectroscopy study. J Affect Disord 135(1-3):354-361. — PubMed
  11. Dolan E, Gualano B, Rawson ES (2019). Beyond muscle: the effects of creatine supplementation on brain creatine, cognitive processing, and traumatic brain injury. Eur J Sport Sci 19(1):1-14. — PubMed
  12. Sakellaris G et al. (2006). Prevention of complications related to traumatic brain injury in children and adolescents with creatine administration. J Trauma 61(2):322-329. — PubMed

PubMed Topic Searches

Back to Table of Contents

Connections

Back to Table of Contents